Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (31-40 of 222) with videos related to

Pageof 23
Sort By:
The Journal of Urology|March 22, 2008
Re: Application of artificial intelligence to the management of urological cancer. M. F. Abbod, J. W. Catto, D. A. Linkens and F. C. Hamdy J Urol 2007; 178: 1150-1156Carsten Stephan, Henning Cammann, Michael Lein, et al.
Clinical Chemistry and Laboratory Medicine|February 27, 2015
Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissueCarsten Stephan, Monika Jung, Silke Rabenhorst, et al.
BMC Cancer|July 20, 2011
Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinomaAngelika Tölle, Saba Suhail, Monika Jung, et al.
Oncology Reports|November 15, 2011
Expression of endothelial factors in prostate cancer: a possible role of caveolin-1 for tumour progressionIsabel Steiner, Klaus Jung, Kurt Miller, et al.
Clinical Chemistry|April 1, 2008
Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9Klaus Jung, Silke Klotzek, Carsten Stephan, et al.
Aktuelle Urologie|April 8, 2026
[Image-Guided Irreversible Electroporation for the Treatment of Localized Prostate Cancer]Federico Collettini, Timo Alexander Auer, Carsten Stephan, et al.
Nature Reviews. Urology|April 7, 2010
Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumorsAnnika Schaefer, Carsten Stephan, Jonas Busch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 20, 2004
Serum macrophage migration inhibitory factor is not elevated in patients with prostate cancerAnja Michael, Carsten Stephan, Dietmar Schnorr, et al.
Nature Reviews. Urology|November 3, 2016
The translational potential of microRNAs as biofluid markers of urological tumoursAnnika Fendler, Carsten Stephan, George M Yousef, et al.
The Prostate|July 13, 2007
S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation studyStefan Ludwig, Carsten Stephan, Michael Lein, et al.
Pageof 23

Showing results (31-40 of 222) with videos related to

Sort By:
Pageof 23
The Journal of Urology|March 22, 2008
Re: Application of artificial intelligence to the management of urological cancer. M. F. Abbod, J. W. Catto, D. A. Linkens and F. C. Hamdy J Urol 2007; 178: 1150-1156Carsten Stephan, Henning Cammann, Michael Lein, et al.
Clinical Chemistry and Laboratory Medicine|February 27, 2015
Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissueCarsten Stephan, Monika Jung, Silke Rabenhorst, et al.
BMC Cancer|July 20, 2011
Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinomaAngelika Tölle, Saba Suhail, Monika Jung, et al.
Oncology Reports|November 15, 2011
Expression of endothelial factors in prostate cancer: a possible role of caveolin-1 for tumour progressionIsabel Steiner, Klaus Jung, Kurt Miller, et al.
Clinical Chemistry|April 1, 2008
Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9Klaus Jung, Silke Klotzek, Carsten Stephan, et al.
Aktuelle Urologie|April 8, 2026
[Image-Guided Irreversible Electroporation for the Treatment of Localized Prostate Cancer]Federico Collettini, Timo Alexander Auer, Carsten Stephan, et al.
Nature Reviews. Urology|April 7, 2010
Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumorsAnnika Schaefer, Carsten Stephan, Jonas Busch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 20, 2004
Serum macrophage migration inhibitory factor is not elevated in patients with prostate cancerAnja Michael, Carsten Stephan, Dietmar Schnorr, et al.
Nature Reviews. Urology|November 3, 2016
The translational potential of microRNAs as biofluid markers of urological tumoursAnnika Fendler, Carsten Stephan, George M Yousef, et al.
The Prostate|July 13, 2007
S100A8, S100A9, and the S100A8/A9 complex in circulating blood are not associated with prostate cancer risk-A re-evaluation studyStefan Ludwig, Carsten Stephan, Michael Lein, et al.
Pageof 23